Eric Hacherl, Ph.D. is Vice President and Head of Manufacturing at Spark Therapeutics, headquartered in Philadelphia, Pennsylvania. In this role, he is responsible for internal and external manufacturing, materials management, and manufacturing science & technology (MS&T). Eric joined Spark in September 2020.
With over 20 years’ experience in the pharmaceutical industry, Eric’s subject matter expertise includes operations, supply chain and MS&T in large-molecule and vaccines, as well as cell and gene therapy. Prior to joining Spark, Eric was Site General Manager and VP of Operations for Catalent Gene Therapy in Baltimore, MD. Earlier in his career he served in increasingly responsible operations and technical roles during his 15 years with Merck & Co.
He holds a Ph.D. in Chemical Engineering from Rutgers University, funded by an NIH Biotechnology Training Fellowship and the U.S. Department of Energy.